Edwards Lifesciences Share Price Today
(NASDAQ: EW)

Name: Edwards Lifesciences Share Price Today (NASDAQ: EW) - Edwards Lifesciences Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Edwards Lifesciences share price is $70.91 & ₹6,059.33 as on 29 Mar 2025, 2.30 'hrs' IST

$70.91

▲

-0.28

(-0.39%)

Market is closed - opens 7 PM, 31 Mar 2025

View live Edwards Lifesciences share price in Dollar and Rupees. Guide to invest in Edwards Lifesciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Edwards Lifesciences, along with analyst recommendations, forecasts, and comprehensive financials.

Edwards Lifesciences share price movements

Today's Low: $70.65
Today's High: $71.65
$70.91
0.37%
Downside
Day's Volatility :1.4%
Upside
1.03%
52 Weeks Low: $58.93
52 Weeks High: $95.73
$70.91
16.89%
Downside
52 Weeks Volatility :38.44%
Upside
25.93%

Edwards Lifesciences (EW) Returns

Period	Edwards Lifesciences Corp.	Sector (Health Care)	Index (Russel 2000)
3 Months	-4.49%	5.1%	0.0%
6 Months	7.46%	-6.2%	0.0%
1 Year	-24.76%	-2.2%	0.0%
3 Years	-42.38%	5.5%	-14.5%

Edwards Lifesciences (EW) Key Statistics

in dollars & INR

Previous Close	$71.19
Open	$70.92
Today's High	$71.65
Today's Low	$70.65
Market Capitalization	$41.5B
Today's Volume	$4.5M
52 Week High	$95.73
52 Week Low	$58.93
Revenue TTM	$5.4B
EBITDA	$1.6B
Earnings Per Share (EPS)	$2.34
PE Ratio	30.3
Profit Margin	76.75%
Quarterly Earnings Growth YOY	0.07%
Return On Equity TTM	16.64%

How to invest in Edwards Lifesciences Stock (EW) from India?

It is very easy for Indian residents to invest directly in Edwards Lifesciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Edwards Lifesciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Edwards Lifesciences or EW on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Edwards Lifesciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Edwards Lifesciences shares which would translate to 0.012 fractional shares of Edwards Lifesciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Edwards Lifesciences, in just a few clicks!

Returns in Edwards Lifesciences (EW) for Indian investors in Rupees

The Edwards Lifesciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Edwards Lifesciences investment value today

Current value as on today

₹77,774

Returns

₹22,226

(-22.23%)

Returns from Edwards Lifesciences Stock

₹24,764 (-24.76%)

Dollar Returns

₹2,538 (+2.54%)

Indian investors sentiment towards Edwards Lifesciences (EW)

-67%

Period: Feb 28, 2025 to Mar 30, 2025. Change in 30 Days versus previous period

Search interest for Edwards Lifesciences Stock from India on INDmoney has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Edwards Lifesciences Stock (EW Ticker)

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	5088	0.10	0.08%

Global Institutional Holdings in Edwards Lifesciences

Vanguard Group Inc
11.76%
BlackRock Inc
9.27%
Wellington Management Company LLP
5.65%
State Street Corp
4.39%
Bank of New York Mellon Corp
3.08%
JPMorgan Chase & Co
2.53%

Analyst Recommendation on Edwards Lifesciences

Buy

60%Buy

35%Hold

5%Sell

Based on 40 Wall street analysts offering stock ratings for Edwards Lifesciences(by analysts ranked 0 to 5 stars)

Based on 40 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Edwards Lifesciences Stock (EW)

What analysts predicted

Upside of 13.02%

Target:

$80.14

Current:

$70.91

Insights on Edwards Lifesciences Stock (Ticker Symbol: EW)

Price Movement
In the last 7 days, EW stock has moved down by -0.6%
Increasing Revenue
Edwards Lifesciences Corp. has seen a positive trend in its revenue over the last two quarters. The company's revenue increased from $1.35 billion to $1.38 billion, averaging a growth of 2.3% per quarter.
Decreasing Net Profit
Edwards Lifesciences Corp. has experienced a significant decline in net profit over the last two quarters. The net profit dropped from $3.07 billion to $385.6 million, reflecting an average decrease of 87.4% each quarter.
EW vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 45.1% return, outperforming this stock by 70.9%
EW vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 124.3% return, outperforming this stock by 164.1%
Price to Sales
Edwards Lifesciences Corp. has a Price-to-Sales Ratio of 7.8. This means that investors are willing to pay $7.8 for every $1 of sales the company generates. In comparison, Boston Scientific Corp. has a higher Price-to-Sales Ratio of 8.7, indicating that investors value its sales more highly.

EW Edwards Lifesciences Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$4.3B	↑ 16.79%
Net Income	$1.0B	↑ 44.96%
Net Profit Margin	24.08%	↑ 4.68%

	FY20	Y/Y Change
Revenue	$4.4B	↑ 0.88%
Net Income	$823.4M	↓ 21.35%
Net Profit Margin	18.77%	↓ 5.31%

	FY21	Y/Y Change
Revenue	$5.2B	↑ 19.29%
Net Income	$1.5B	↑ 82.55%
Net Profit Margin	28.73%	↑ 9.96%

	FY22	Y/Y Change
Revenue	$5.4B	↑ 2.86%
Net Income	$1.5B	↑ 1.25%
Net Profit Margin	28.28%	↓ 0.45%

	FY23	Y/Y Change
Revenue	$6.0B	↑ 11.56%
Net Income	$1.4B	↓ 7.85%
Net Profit Margin	23.35%	↓ 4.93%

	FY24	Y/Y Change
Revenue	$5.4B	↓ 9.41%
Net Income	$4.2B	↑ 197.68%
Net Profit Margin	76.75%	↑ 53.4%

	Q3 FY23	Q/Q Change
Revenue	$1.5B	↓ 3.22%
Net Income	$384.9M	↑ 25.33%
Net Profit Margin	25.99%	↑ 5.92%

	Q4 FY23	Q/Q Change
Revenue	$1.5B	↑ 3.59%
Net Income	$369.9M	↓ 3.9%
Net Profit Margin	24.11%	↓ 1.88%

	Q1 FY24	Q/Q Change
Revenue	$1.6B	↑ 4.18%
Net Income	$351.9M	↓ 4.87%
Net Profit Margin	22.02%	↓ 2.09%

	Q2 FY24	Q/Q Change
Revenue	$1.4B	↓ 13.28%
Net Income	$366.3M	↑ 4.09%
Net Profit Margin	26.43%	↑ 4.41%

	Q3 FY24	Q/Q Change
Revenue	$1.4B	↓ 2.27%
Net Income	$3.1B	↑ 738.33%
Net Profit Margin	226.73%	↑ 200.3%

	Q4 FY24	Q/Q Change
Revenue	$1.4B	↑ 2.32%
Net Income	$385.6M	↓ 87.44%
Net Profit Margin	27.83%	↓ 198.9%

	FY19	Y/Y Change
Profit	$3.2B	↑ 16.17%

	FY20	Y/Y Change
Profit	$3.3B	↑ 2.23%

	FY21	Y/Y Change
Profit	$4.0B	↑ 20.51%

	FY22	Y/Y Change
Profit	$4.3B	↑ 7.99%

	FY23	Y/Y Change
Profit	$4.6B	↑ 7.51%

	FY24	Y/Y Change
Profit	$4.3B	↓ 6.55%

	Q3 FY23	Q/Q Change
Profit	$1.1B	↓ 4.78%

	Q4 FY23	Q/Q Change
Profit	$1.2B	↑ 4.13%

	Q1 FY24	Q/Q Change
Profit	$1.2B	↑ 3.13%

	Q2 FY24	Q/Q Change
Profit	$1.1B	↓ 10.37%

	Q3 FY24	Q/Q Change
Profit	$1.1B	↑ 0.31%

	Q4 FY24	Q/Q Change
Profit	$1.1B	↑ 0.19%

	FY19	Y/Y Change
Operating Cash Flow	$1.2B	↑ 27.26%
Investing Cash Flow	$-595.8M	↓ 876.79%
Financing Cash Flow	$-115.6M	↓ 89.5%

	FY20	Y/Y Change
Operating Cash Flow	$1.1B	↓ 10.61%
Investing Cash Flow	$-531.1M	↓ 10.86%
Financing Cash Flow	$-486.9M	↑ 321.19%

	FY21	Y/Y Change
Operating Cash Flow	$1.7B	↑ 64.29%
Investing Cash Flow	$-1.7B	↑ 224.33%
Financing Cash Flow	$-356.3M	↓ 26.82%

	FY22	Y/Y Change
Operating Cash Flow	$1.2B	↓ 29.67%
Investing Cash Flow	$252.3M	↓ 114.65%
Financing Cash Flow	$-1.6B	↑ 344.71%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$411.5M	↑ 1124.7%
Investing Cash Flow	$159.7M	↑ 127.49%
Financing Cash Flow	$-143.3M	↓ 375.05%

Edwards Lifesciences Technicals Summary

Sell

Neutral

Buy

Edwards Lifesciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Edwards Lifesciences (EW) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Edwards Lifesciences Corp.	-0.67%	7.46%	-24.76%	-42.38%	23.23%
Medtronic Plc	-7.07%	-2.67%	0.7%	-22.12%	4.18%
Boston Scientific Corp.	-5.25%	18.57%	45.9%	120.85%	229.12%
Stryker Corporation	-7.69%	0.9%	2.77%	35.48%	151.95%
Abbott Laboratories	-6.7%	14.74%	16.71%	10.32%	70.85%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Edwards Lifesciences Corp.	30.3	30.3	4.26	2.45	0.17	0.08	NA	16.99
Medtronic Plc	26.72	26.72	1.53	5.45	0.08	0.05	0.03	38.49
Boston Scientific Corp.	79.49	79.49	1.98	2.86	0.09	0.05	NA	14.76
Stryker Corporation	46.97	46.97	2.08	13.48	0.15	0.07	0.01	54.1
Abbott Laboratories	17.12	17.12	4.17	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Edwards Lifesciences Corp.	Buy	$41.5B	23.23%	30.3	76.75%
Medtronic Plc	Buy	$112.4B	4.18%	26.72	12.83%
Boston Scientific Corp.	Buy	$147.0B	229.12%	79.49	11.07%
Stryker Corporation	Buy	$139.1B	151.95%	46.97	13.25%
Abbott Laboratories	Buy	$226.9B	70.85%	17.12	31.95%

About Edwards Lifesciences

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Organization	Edwards Lifesciences
Employees	15800
CEO	Mr. Bernard J. Zovighian
Industry	Health Technology

Management People of Edwards Lifesciences

Name	Title
Mr. Bernard J. Zovighian	CEO & Director
Mr. Scott B. Ullem	Corporate VP & CFO
Mr. Donald E. Bobo Jr.	Corporate Vice President of Strategy & Corporate Development
Mr. Larry L. Wood	Corporate VP and Group President of TAVR & Surgical Structural Heart
Mr. Jean-Luc Lemercier	Corporate Vice President of Japan, Asia Pacific & Greater China
Mr. Daveen Chopra	Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies
Mr. Andrew M. Dahl	Principal Accounting Officer, Senior VP & Corporate Controller
Dr. Todd J. Brinton FACC, M.D.	Corporate VP of Advanced Technology & Chief Scientific Officer
Mr. Mark Wilterding	Vice President of Investor Relations
Mr. Arnold A. Pinkston J.D.	Corporate VP & General Counsel

Important FAQs about investing in EW Stock from India :

What is Edwards Lifesciences share price today?

Edwards Lifesciences share price today stands at $70.91, Open: $70.92 ; Previous Close: $71.19 ; High: $71.65 ; Low: $70.65 ; 52 Week High: $95.73 ; 52 Week Low: $58.93.

The stock opens at $70.92, after a previous close of $71.19. The stock reached a daily high of $71.65 and a low of $70.65, with a 52-week high of $95.73 and a 52-week low of $58.93.

Can Indians buy Edwards Lifesciences shares?

Yes, Indians can invest in the Edwards Lifesciences (EW) from India.

With INDmoney, you can buy Edwards Lifesciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Edwards Lifesciences at zero transaction cost.

How can I buy Edwards Lifesciences shares from India?

It is very easy to buy Edwards Lifesciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Edwards Lifesciences (EW) be purchased?

Yes, you can buy fractional shares of Edwards Lifesciences with INDmoney app.

What are the documents required to start investing in Edwards Lifesciences stocks?

To start investing in Edwards Lifesciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.